CLOV vs NVAX · rev $1.37B vs P/E 2.5, rev $682.2M
Clover Health Investments Corp (CLOV) versus Novavax Inc (NVAX) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Novavax Inc (NVAX) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported NVAX revenue for 2024-12-31 was $682.2M. Net income was -$187.5M. Revenue was down 30.7% from 2023-12-31 to 2024-12-31. NVAX currently screens at market cap $1.09B and trailing P/E 2.5.
CLOV currently screens at market cap $1.55B. NVAX currently screens at market cap $1.09B and trailing P/E 2.5.
Not investment advice. Open the CLOV and NVAX stock pages for the full models.
Not investment advice.